Skip to main content
Administrator Guide
Last Updated: 2026-05-15
Steps: Set Up Alternate Fiscal Year Consolidations in AP&C

Steps: Set Up Alternate Fiscal Year Consolidations in AP&C

  • Review setup considerations for consolidations and eliminations.
  • Create Organization Hierarchies.
    Create a company hierarchy that includes all companies that are part of the consolidation.
  • Ensure you’ve recorded the Primary Fiscal Schedule opening balances using the Journal Enterprise Interface Builder (EIB).
  • Security:
    • Set Up: Consolidation
      domain in the Financial Accounting functional area.
    • Set Up: Financial Accounting
      domain in the Common Financial Management functional area.
Workday enables you to create consolidated financial statements for companies with different fiscal schedules in Adaptive Planning and Consolidation (AP&C). When you want to roll up companies with alternate fiscal schedules into a hierarchy, each company in the hierarchy must share either:
  • The same primary fiscal schedule. For a consolidation with equity pickup or noncontrolling interest, companies must share the same primary fiscal schedule for the tasks to run.
  • The same alternate fiscal schedule.
Also ensure:
  • You create an alternate fiscal schedule for all years that have data.
  • You roll forward the alternate fiscal year for each year that has data.
Create a separate hierarchy if you want to report consolidation results for the alternate fiscal schedule.
  1. Consolidate companies in the hierarchy to record:
    • Intercompany elimination.
    • Equity pickup.
    • Noncontrolling interest (NCI).
  2. Associate 1 or more alternate fiscal schedules with each company in the hierarchy.
  3. Access the
    Edit Consolidation Details
    task and enter a standard or alternate fiscal year to define the consolidation fiscal schedule for the company hierarchy.
  4. Roll forward year-end balances and translated beginning balances for all companies in the hierarchy at the end of their fiscal years.
Run the
Consolidated Trial Balance
report.